N/A
N=322
Diagnosis of Tuberculosis Infection in Health Care Workers Using Ex-vivo Interferon-gamma Assay
Latent Tuberculosis Infection
Bottom Line
View on ClinicalTrials.gov: NCT01007396 ↗Enrolled (actual)
322
Serious AEs
—
Results posted
Jan 2012
Primary outcome: Primary: Annual Incidence of Tuberculosis Infection Among Newly Employed Doctors and Nurses in Korea — 57 number of new cases per 1000 person/year
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- 1-step tuberculin skin test (TST) and blood sampling (Other)
- Age
- Pediatric, Adult, Older Adult
- Sex
- All
- Sponsor
- Samsung Medical Center
- Primary completion
- Dec 2009
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Annual Incidence of Tuberculosis Infection Among Newly Employed Doctors and Nurses in Korea |
57 | — |
| SECONDARY Negative Conversion Rate in Follow-up QuantiFERON-TB Gold In-Tube Test (QFT-IT Test) After Treatment of Latent Tuberculosis Infection (LTBI) |
15 | — |
Summary
The present study was to evaluate the usefulness of a whole-blood interferon-r release assays (IGRAs) as diagnostic tool of the latent tuberculosis infection for healthcare workers.
Eligibility Criteria
Inclusion Criteria
- doctors and nurses newly hired at Samsung Medical Center between February, 2008 and November, 2008.
Exclusion Criteria
- Non-applicable
Data sourced from ClinicalTrials.gov (NCT01007396). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.